Target intelligence / Profile preview

TM2 domain-containing protein 2 (TM2D2)

Target
TM2D2
Molecular classification
Other (structural similarity to G protein-coupled receptor superfamily, but not a canonical GPCR), transmembrane protein
01

Overview

TM2 domain-containing protein 2 (TM2D2) is a membrane protein containing a module structurally related to the seven transmembrane domain G protein-coupled receptor superfamily, though it is not itself a canonical GPCR[2][3]. It is homologous to beta-amyloid binding protein (BBP), but, unlike BBP, does not regulate responses to beta-amyloid peptide. TM2D2 may be involved in regulatory processes affecting cell death or proliferation, as suggested by its sequence features and some experimental parallels to TM2D family members implicated in Notch signaling regulation and neurodevelopment in model organisms[1][2][3]. Mutations in related TM2D genes (e.g., TM2D3) are associated with neurological deficits and neurodegenerative phenotypes in animal models, but there is limited direct evidence for TM2D2’s role in human disease outside of its association with a congenital myopathy[1][3]. It is not currently an established therapeutic target and no drugs or biomarkers are known for this protein.

Other names
BLP1BBP-like protein 1beta-amyloid-binding protein-like protein 1TM2D2TM2 domain-containing protein 2
02

Mechanism of action

Not established; no drugs currently target this protein specifically

03

Biological functions

Putative regulatory roles in cell death signal cascadesPutative regulatory roles in cell proliferation signal cascadesPossible modulation of Notch signaling (based on TM2D gene family functions)
04

Disease associations

Possible involvement in neurodevelopmental disorders (based on Drosophila orthologs)Potential link to neurodegenerative disease (by analogy with TM2D family, though specific evidence for TM2D2 is lacking)[1]Congenital myopathy 4A, autosomal dominant (per disease association listings)[3]

Beyond the preview

Go deeper on TM2 domain-containing protein 2 (TM2D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TM2 domain-containing protein 2 (TM2D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call